GLP-1 medications like Ozempic, Zepbound and Wegovy are revolutionizing weight management, but with their growing popularity ...
Kyverna Therapeutics (KYTX) is rated a strong buy with promising KYV-101 Phase 2 data and near-term catalysts. Read here for ...
VANCOUVER, BC / ACCESS Newswire / November 12, 2025 / American Critical Minerals Corp. (“American Critical Minerals” or the ...
Syntheia Corp. (CSE: SYAI) (“Syntheia” or the “Company”) (syntheia.ai) is pleased to announce that it intends to settle an aggregate of $590,768.
Fintel reports that on November 14, 2025, Morgan Stanley downgraded their outlook for Ardent Health (NYSE:ARDT) from Overweight to Equal-Weight. Analyst Price Forecast Suggests 112.96% Upside As of ...
Willis Lease Finance now trades at a 34% discount to adjusted book value, following a 40% YTD price drop despite strong ...
Aardvark has aligned with the FDA to reduce the minimum age of eligibility from 13 to 10 years old for pediatric patients in HERO, the Phase 3 trial of ARD-101 for the treatment of hyperphagia associa ...
Centurion Minerals Ltd. (TSXV: CTN) ("Centurion", or the "Company") is pleased to announce that it has closed a first tranche of ...
TORONTO, ON / ACCESS Newswire / November 14, 2025 / Axcap Ventures Inc. ("Axcap") and Taura Gold Inc. ("Taura") are pleased to announce the results of the annual general and special meeting of ...
Euro Sun Mining Inc., (TSX: ESM) ('Euro Sun”, 'ESM”, or the 'Company”) is delighted to announce that under an Emergency ...
Galantas Gold Corporation (TSX-V & AIM: GAL; OTCQB: GALKF) (“Galantas” or the “Company”) is pleased to announce that it has entered into a share purchase agreement (the “Share Purchase Agreement”), ...
Not for distribution to U.S. newswire services or dissemination in the United States TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Galantas Gold Corporation (TSX-V & AIM: GAL; OTCQB: GALKF) ("Galantas" ...